Xcell Therapeutics CEO · 1 stock
Calculated from quantities and prices in the filings, or the closing price where a filing omits prices (short-form filings such as the NPS). A change reported in both a 5% filing and an insider filing is counted once
Indirect stakes multiply ownership through listed companies. Stakes through unlisted companies and holdings under 5% are not filed. Values overlap through subsidiaries, so do not add them up.